What does a migraine cocktail typically consist of in an Emergency Room (ER) setting?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Migraine Cocktail Components in the Emergency Room

The most effective ER migraine cocktail consists of IV metoclopramide 10 mg plus IV ketorolac 30 mg as first-line combination therapy, with prochlorperazine 10 mg IV as an equally effective alternative to metoclopramide. 1, 2

Core Components

Primary Agents (Choose One Dopamine Antagonist)

  • Metoclopramide 10 mg IV provides both antiemetic effects and synergistic analgesia for migraine pain, making it the most commonly recommended dopamine antagonist 1, 2, 3
  • Prochlorperazine 10 mg IV is equally effective to metoclopramide for headache relief and has demonstrated >70% efficacy in multiple studies 1, 3, 4
  • Both agents work as monotherapy but are more effective when combined with NSAIDs 3

NSAID Component

  • Ketorolac 30-60 mg IV/IM serves as the primary NSAID with rapid onset (approximately 6 hours duration) and minimal rebound headache risk 1, 2
  • Use 30 mg IV for patients ≥65 years or with renal impairment; 60 mg IM for younger patients without contraindications 1

Alternative and Add-On Agents

When First-Line Fails

  • Dihydroergotamine (DHE) parenteral or intranasal formulations for severe, refractory cases 5, 1, 2
  • Magnesium sulfate 1 gram IV showed superior pain reduction compared to ketorolac alone in head-to-head trials 6
  • Dexamethasone 8 mg IV combined with metoclopramide achieved equivalent 2-hour pain relief to ketorolac, though with slower onset 7

Migraine-Specific Agents

  • Subcutaneous sumatriptan for severe presentations when oral route is compromised by nausea/vomiting 5, 1, 2
  • Triptans should be administered early in the attack for maximum efficacy 1, 2

What NOT to Include

  • Avoid opioids (including meperidine/pethidine) as they lead to dependency, rebound headaches, and are inferior to dopamine antagonists 1, 8, 3
  • Avoid diphenhydramine as a routine component unless specifically preventing extrapyramidal side effects from high-dose phenothiazines 1
  • Prednisone has limited evidence for acute treatment and is more appropriate for status migrainosus 1

Administration Algorithm

For typical acute migraine in ER:

  1. Start with metoclopramide 10 mg IV + ketorolac 30 mg IV simultaneously 1, 2
  2. Reassess at 1 hour; if inadequate response, add magnesium sulfate 1 gram IV or DHE 6
  3. If nausea predominates, prochlorperazine 10 mg IV can replace metoclopramide with equivalent efficacy 1, 3

For severe/refractory presentations:

  1. Consider dexamethasone 8 mg IV + metoclopramide 10 mg IV for longer-lasting effect 7
  2. Add subcutaneous sumatriptan if vascular headache features predominate 2, 4

Critical Cautions

  • Akathisia risk is highest with droperidol and prochlorperazine; consider prophylactic diphenhydramine only if using high doses 3
  • Limit acute treatment to ≤2 times weekly to prevent medication-overuse headache 1, 8
  • Ketorolac contraindications include renal impairment, GI bleeding history, and significant cardiovascular disease 1
  • Metoclopramide contraindications include pheochromocytoma, seizure disorder, GI bleeding, and GI obstruction 1
  • Avoid triptans in uncontrolled hypertension, coronary artery disease, or basilar/hemiplegic migraine 2

References

Guideline

Acute Headache Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Migraine Management with Combination Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Migraine: pharmacotherapy in the emergency department.

Journal of accident & emergency medicine, 2000

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Cannabis-Induced Headache/Migraine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.